Tvardi Therapeutics, Inc.
TVRD
$3.98
$0.020.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.80M | -7.28M | -5.53M | 4.17M | -9.58M |
| Total Depreciation and Amortization | 24.00K | 24.00K | 24.00K | 23.00K | 24.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 355.00K | 338.00K | 332.00K | -12.08M | 5.53M |
| Change in Net Operating Assets | 566.00K | 1.23M | 914.00K | 2.03M | -3.66M |
| Cash from Operations | -5.86M | -5.69M | -4.26M | -5.87M | -7.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.98M | 5.00M | 5.35M | -9.55M | -10.88M |
| Cash from Investing | 4.98M | 5.00M | 5.35M | -9.55M | -10.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1.00K | 107.00K | 421.00K | 3.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -429.00K | 24.21M | -1.61M |
| Cash from Financing | -- | 1.00K | -322.00K | 24.63M | -1.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -883.00K | -684.00K | 770.00K | 9.21M | -20.18M |